KRW 2550.0
(-0.97%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 11.67 Billion | -8.83 Billion | -3.67 Billion | 16.67 Billion | 7.23 Billion | -11.8 Billion |
Net Income | 4.35 Billion | -11.11 Billion | -926.4 Million | 1.63 Billion | 818.83 Million | -5.96 Billion |
Depreciation & Amortization | 584.01 Million | 1.68 Billion | 1.8 Billion | 1.78 Billion | 2.44 Billion | 2.66 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 7.34 Billion | -8 Billion | -4.95 Billion | 11.34 Billion | 2.23 Billion | -15.73 Billion |
Other non-cash items | -7.37 Billion | 18.6 Billion | 7.94 Billion | -6.24 Billion | 2.59 Billion | 30.29 Billion |
Investing Cash Flow | -3.21 Billion | 5.41 Billion | -3.53 Billion | -722.9 Million | 1.96 Billion | 4.84 Billion |
Investments in PPE | -3.6 Billion | -960.55 Million | -1.68 Billion | -1.41 Billion | -823.14 Million | -1.57 Billion |
Acquisitions | 1.59 Billion | 125.67 Million | 21.26 Million | 3 Million | 599 Million | 361.3 Million |
Investment purchases | -7.46 Billion | -440.98 Million | -7.79 Billion | -1.48 Billion | -1.06 Billion | -461.89 Million |
Sales/Maturities of investments | 5.31 Billion | 7.24 Billion | 5.24 Billion | 1.46 Billion | 2.33 Billion | 1.01 Billion |
Other Investing Activities | 956.52 Million | -557.82 Million | 675.13 Million | 703.4 Million | 922.57 Million | 5.49 Billion |
Financing Cash Flow | -212.88 Million | -9.8 Billion | -7.63 Billion | -1.13 Billion | -837.5 Million | 14.27 Billion |
Debt repayment | -154.97 Million | -9.72 Billion | -7.5 Billion | -1 Billion | -837.5 Million | -14.27 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 8150.00 | 1400.00 | - | - |
Other Financing Activities | -57.91 Million | 10.00 | - | - | - | - |
Accounts receivables | 340.77 Million | -778.84 Million | 1.03 Billion | 7.53 Billion | -3.84 Billion | -881.63 Million |
Accounts payables | 7.67 Billion | -4.37 Billion | -5.74 Billion | -3.51 Billion | 5.96 Billion | -10.85 Billion |
Inventory | -73.49 Million | -1.48 Billion | 777.86 Million | 7.7 Billion | 1.91 Billion | -6 Billion |
Other working capital | -594.47 Million | -1.37 Billion | -1.02 Billion | -375.55 Million | -1.79 Billion | 2.01 Billion |
Cash at beginning of period | 11.26 Billion | 24.48 Billion | 39.17 Billion | 23.36 Billion | 16.11 Billion | 8.82 Billion |
Cash at end of period | 19.53 Billion | 11.26 Billion | 24.48 Billion | 39.17 Billion | 23.36 Billion | 16.11 Billion |
Capital Expenditure | -3.6 Billion | -960.55 Million | -1.68 Billion | -1.41 Billion | -823.14 Million | -1.57 Billion |
Effect of forex changes on cash | 22.75 Million | 2.13 Million | 165.76 Million | 4.78 Million | - | - |
Net cash flow / Change in cash | 8.26 Billion | -13.21 Billion | -14.68 Billion | 15.8 Billion | 7.24 Billion | 7.29 Billion |
Free Cash Flow | 8.06 Billion | -9.79 Billion | -5.35 Billion | 15.25 Billion | 6.41 Billion | -13.38 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.08 Billion | 1.16 Billion | 4.35 Billion | 1.51 Billion | 352.27 Million | 1.07 Billion |
Depreciation & Amortization | 237.44 Million | 170.41 Million | 584.01 Million | 161.35 Million | 155.46 Million | 136.9 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -4.99 Billion | -1.13 Billion | 7.34 Billion | 1.75 Billion | 28.23 Million | 2.7 Billion |
Other non-cash items | 5.21 Billion | 3.2 Billion | -7.37 Billion | -4.91 Billion | 4.5 Billion | -3.09 Billion |
Investing Cash Flow | -1.34 Billion | -3.45 Billion | -3.21 Billion | 6.52 Billion | -729.78 Million | -6.28 Billion |
Investments in PPE | -1.11 Billion | -254.61 Million | -3.6 Billion | -43.2 Million | -668.38 Million | -1.14 Billion |
Acquisitions | 2.01 Billion | 20.58 Million | 1.59 Billion | 1.28 Billion | 3.5 Million | - |
Investment purchases | -163.89 Million | -5.16 Billion | -7.46 Billion | -161.99 Million | -161.99 Million | -5.07 Billion |
Sales/Maturities of investments | -2 Billion | 2 Billion | 5.31 Billion | 5 Billion | 21.7 Million | 310 Million |
Other Investing Activities | -73 Million | -51.6 Million | 956.52 Million | 442.5 Million | 97.09 Million | 136.91 Million |
Financing Cash Flow | -47.55 Million | -10.66 Million | -212.88 Million | -11.53 Million | -12.07 Million | -17.35 Million |
Debt repayment | - | - | -154.97 Million | -10.00 | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -47.55 Million | - | - | - | - | - |
Accounts receivables | 3.14 Billion | 1.63 Billion | 340.77 Million | 1.23 Billion | -2.41 Billion | 7.82 Billion |
Accounts payables | -637.88 Million | 453.62 Million | 7.67 Billion | -842.09 Million | 3.06 Billion | -3.84 Billion |
Inventory | -7.14 Billion | -4.75 Billion | -73.49 Million | 4.43 Billion | -4.6 Billion | -599.85 Million |
Other working capital | -353.52 Million | 1.53 Billion | -594.47 Million | -3.07 Billion | 3.98 Billion | -769.82 Million |
Cash at beginning of period | 16.49 Billion | 19.53 Billion | 11.26 Billion | 10.04 Billion | 10.04 Billion | 12.42 Billion |
Cash at end of period | 11.55 Billion | 16.49 Billion | 19.53 Billion | 19.53 Billion | 10.04 Billion | 10.04 Billion |
Capital Expenditure | -1.11 Billion | -254.61 Million | -3.6 Billion | -43.2 Million | -668.38 Million | -1.14 Billion |
Effect of forex changes on cash | - | 29.8 Million | 22.75 Million | -51.53 Million | -34.14 Million | -14.15 Million |
Net cash flow / Change in cash | -4.94 Billion | -3.03 Billion | 8.26 Billion | 9.49 Billion | -2.58 Million | -2.38 Billion |
Free Cash Flow | -4.68 Billion | 140.14 Million | 8.06 Billion | 2.98 Billion | 105.03 Million | 2.78 Billion |
BMT
DIPGF
POSC
8105
SWGHF
3719